Lymphocyte function in inflammatory disorders of human endometrium and decidua
淋巴细胞在人子宫内膜和蜕膜炎症性疾病中的功能
基本信息
- 批准号:10673395
- 负责人:
- 金额:$ 62.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-01 至 2028-04-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAllograftingAntigensArchivesAutoantigensAutoimmuneB cell therapyB-LymphocytesBedsCD8-Positive T-LymphocytesCRISPR/Cas technologyCell LineCell LineageCell physiologyCellsCellular Indexing of Transcriptomes and Epitopes by SequencingChronicDataDeciduaDecidual CellDevelopmentDevelopmental ProcessDiagnosticDiseaseEndometrialEndometriumEnsureEnvironmentEpigenetic ProcessEpithelial CellsEventFemaleFertilityFetal DevelopmentFibroblastsFirst Pregnancy TrimesterFosteringFrequenciesGenesGoalsHumanImmuneImmunologicsImpairmentInfectionInfertilityInflammationInflammatoryInvadedKnowledgeLymphocyteLymphocyte FunctionLymphocyte SubsetMaternal-Fetal ExchangeMediatingMediatorMenstrual cycleModelingNatural Killer CellsObesityPathogenesisPathway interactionsPatientsPeptidesPhasePhenotypePlacentationPolycystic Ovary SyndromePopulationPregnancyPregnancy OutcomeProcessProteomeRegulatory T-LymphocyteReproductionRoleSpecificitySpecimenSpiral Artery of the EndometriumStainsSubgroupSystemT-Cell Immunologic SpecificityT-LymphocyteTherapeuticThinnessTissuesUterusVascular remodelingVillousWomanWorkcomorbidityearly pregnancyearly pregnancy lossendometriosisexperimental studyfailure Implantationfetalimmunoregulationimplantationimprovedinsightmicrobialnatural Blastocyst Implantationnovelobese patientsprospectivereproductivereproductive outcomereproductive successsingle cell technologysubfertilitysuccesstranscriptometrophoblast
项目摘要
Endometriosis and polycystic ovary syndrome (PCOS) are major causes of female subfertility and infertility. Each
is accompanied by chronic endometrial inflammation triggered and perpetuated by uncertain mechanisms.
Potential roles for immune cells, specifically T and B lymphocytes, in endometrial inflammation are largely
unexplored despite their being key orchestrators and mediators of tissue inflammation in many other non-uterine
contexts. Furthermore, the antigen specificities of endometrial T and B cells are not well described, and whether
self-antigen specific clones contribute to disorders with poor reproductive outcomes is unclear, despite evidence
that endometriosis, in particular, may have an autoimmune component. These knowledge gaps represent major
opportunities for improving reproductive outcomes for infertile patients with endometriosis and PCOS. Moreover,
these disorders represent ideal models for investigating how immune dysregulation in the endometrium may
contribute to infertility and subfertility more broadly. Accordingly, the goal of this project is to determine how T
and B cells contribute to the pathogenesis of endometrial inflammation and, by extension, decidual inflammation,
relevant to implantation failure and poor pregnancy outcomes. Herein, we propose to deeply characterize the
frequencies, transcriptomes, proteomes, TCR/BCR repertoires, and antigen specificities of endometrial and
decidual T and B cells across the menstrual cycle and in early pregnancy, respectively, in the context of healthy
women (Aim 1) and those with endometriosis and PCOS (Aim 2). Particular emphasis will be placed on regulatory
lymphocytes, which include conventional CD4+ regulatory T cells (Tregs), and cells from the CD8+ T cell and B
cell lineages, since these cells are likely critical for ensuring a controlled inflammatory microenvironment optimal
for implantation and successful pregnancy. Since the differentiation and function of these cells can be locally
influenced by non-immune endometrial and decidual cells, such as stromal fibroblasts, Aim 3 will define the role
of such cells in supporting suppressive lymphocyte differentiation and identify the key regulators involved in
these processes. The proposal will also determine how endometriosis and PCOS alter the phenotypes of the NK
cell lineage of lymphocytes, given the contribution of NK cells to important developmental events of early
pregnancy. The Aims will be accomplished using archived and prospectively collected endometrial/decidual
specimens from a total of 150 well-characterized subjects. Our central hypothesis is that different lymphocyte
subsets with diverse roles in immunoregulation and microbial defense work together in a coordinated fashion to
establish and maintain the appropriate endometrial and decidual environment for pregnancy success, and that
these cells are altered and derailed by inflammatory disorders associated with poor reproductive outcomes.
Completion of this study will reveal fundamental insights into lymphocyte contributions to tolerance and can
reveal new targets for diagnostics and therapeutics to improve reproductive success.
子宫内膜异位症和多囊卵巢综合征(PCOS)是女性生育力低下和不孕的主要原因。每个
伴随着由不确定的机制引发和延续的慢性子宫内膜炎症。
免疫细胞,特别是T和B淋巴细胞在子宫内膜炎症中的潜在作用主要是
尽管它们是许多其他非子宫内膜组织炎症的关键协调者和介质,
contexts.此外,子宫内膜T和B细胞的抗原特异性还没有很好的描述,
尽管有证据表明,自身抗原特异性克隆导致生殖结果不良的疾病尚不清楚,
尤其是子宫内膜异位症可能有自身免疫成分。这些知识差距代表了
改善子宫内膜异位症和多囊卵巢综合征不孕患者生殖结局的机会。此外,委员会认为,
这些疾病代表了研究子宫内膜免疫失调如何
更广泛地导致不育和生育力低下。因此,本项目的目标是确定T
和B细胞有助于子宫内膜炎症的发病机制,并且通过扩展,有助于蜕膜炎症,
与着床失败和不良妊娠结局有关。在此,我们建议深入描述
频率,转录组,蛋白质组,TCR/BCR库,和抗原特异性的子宫内膜和
蜕膜T和B细胞在整个月经周期和妊娠早期,分别在健康的背景下,
女性(目标1)和子宫内膜异位症和PCOS患者(目标2)。将特别强调监管
淋巴细胞,其包括常规的CD 4+调节性T细胞(T细胞),以及来自CD 8 + T细胞和B细胞的细胞
细胞谱系,因为这些细胞可能对于确保受控的炎症微环境最佳至关重要
植入和成功怀孕。由于这些细胞的分化和功能可以在局部
受非免疫性子宫内膜和蜕膜细胞如间质成纤维细胞的影响,Aim 3将确定其作用
这些细胞在支持抑制性淋巴细胞分化中的作用,并确定参与
这些过程。该提案还将确定子宫内膜异位症和PCOS如何改变NK细胞的表型。
淋巴细胞的细胞谱系,考虑到NK细胞对早期重要发育事件的贡献,
怀孕将使用存档和前瞻性采集的子宫内膜/蜕膜
样本来自150名特征良好的受试者。我们的核心假设是不同的淋巴细胞
在免疫调节和微生物防御中具有不同作用的亚群以协调的方式一起工作,
建立和维持适当的子宫内膜和蜕膜环境,以确保妊娠成功,
这些细胞被与不良生殖结果相关的炎症性疾病改变和破坏。
这项研究的完成将揭示淋巴细胞对耐受性的贡献的基本见解,
揭示了诊断和治疗的新目标,以提高生殖成功率。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Heather Huddleston其他文献
Heather Huddleston的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Establishment of novel osteochondral allografting combined with growth factor- collagen-binding domain fusion technology
新型同种异体骨软骨移植联合生长因子-胶原蛋白结合域融合技术的建立
- 批准号:
26462277 - 财政年份:2014
- 资助金额:
$ 62.62万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Translating PTH Therapy as an Adjuvant for Structural Allografting
将 PTH 疗法转化为结构性同种异体移植的佐剂
- 批准号:
8344380 - 财政年份:2012
- 资助金额:
$ 62.62万 - 项目类别:
Composite Allografting for Promoting Survival of Corneal Transplants
复合同种异体移植促进角膜移植的存活
- 批准号:
7878675 - 财政年份:2009
- 资助金额:
$ 62.62万 - 项目类别:
Composite Allografting for Promoting Survival of Corneal Transplants
复合同种异体移植促进角膜移植的存活
- 批准号:
7677758 - 财政年份:2009
- 资助金额:
$ 62.62万 - 项目类别:
Augmenting Antitumor Immunity after Allografting
增强同种异体移植后的抗肿瘤免疫力
- 批准号:
7466112 - 财政年份:2008
- 资助金额:
$ 62.62万 - 项目类别:
Augmenting Antitumor Immunity after Allografting
增强同种异体移植后的抗肿瘤免疫力
- 批准号:
8010394 - 财政年份:2008
- 资助金额:
$ 62.62万 - 项目类别:
Augmenting Antitumor Immunity after Allografting
增强同种异体移植后的抗肿瘤免疫力
- 批准号:
8208131 - 财政年份:2008
- 资助金额:
$ 62.62万 - 项目类别:
Augmenting Antitumor Immunity after Allografting
增强同种异体移植后的抗肿瘤免疫力
- 批准号:
7575273 - 财政年份:2008
- 资助金额:
$ 62.62万 - 项目类别:
Augmenting Antitumor Immunity after Allografting
增强同种异体移植后的抗肿瘤免疫力
- 批准号:
7765518 - 财政年份:2008
- 资助金额:
$ 62.62万 - 项目类别:














{{item.name}}会员




